These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36894866)

  • 1. 5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort study.
    Atia O; Goren I; Fischler TS; Weisband YL; Greenfeld S; Kariv R; Ledderman N; Matz E; Rimon RM; Dotan I; Turner D; Yanai H
    Aliment Pharmacol Ther; 2023 May; 57(9):1004-1013. PubMed ID: 36894866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gordon M; Taylor K; Akobeng AK; Thomas AG
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.
    Gjuladin-Hellon T; Gordon M; Iheozor-Ejiofor Z; Akobeng AK
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD008414. PubMed ID: 31220875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.
    Gordon M; Naidoo K; Thomas AG; Akobeng AK
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008414. PubMed ID: 21249709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiopurines Have Longer Treatment Durability than Methotrexate in Adults and Children with Crohn's Disease: A Nationwide Analysis from the epi-IIRN Cohort.
    Atia O; Friss C; Ledderman N; Greenfeld S; Kariv R; Daher S; Yanai H; Loewenberg Weisband Y; Matz E; Dotan I; Turner D
    J Crohns Colitis; 2023 Nov; 17(10):1614-1623. PubMed ID: 37099729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and endoscopic outcomes of patients with colonic Crohn's disease treated with 5-aminosalicylates as monotherapy.
    Castillo-Regalado E; Ríos R; Aràjol C; Gely C; Márquez L; Calafat M; González-Muñoza C; Cañete F; Mesonero F; Guardiola J; Garcia-Planella E; Mañosa M; Domènech E
    Gastroenterol Hepatol; 2023 Mar; 46(3):164-170. PubMed ID: 36179946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for maintenance of surgically induced remission in Crohn's disease: a network meta-analysis.
    Iheozor-Ejiofor Z; Gordon M; Clegg A; Freeman SC; Gjuladin-Hellon T; MacDonald JK; Akobeng AK
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013210. PubMed ID: 31513295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC; Wang Y; MacDonald JK; Hanauer S
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008870. PubMed ID: 27372735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gjuladin-Hellon T; Iheozor-Ejiofor Z; Gordon M; Akobeng AK
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD010233. PubMed ID: 31425621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD study.
    Burisch J; Bergemalm D; Halfvarson J; Domislovic V; Krznaric Z; Goldis A; Dahlerup JF; Oksanen P; Collin P; de Castro L; Hernandez V; Turcan S; Belousova E; D'Incà R; Sartini A; Valpiani D; Giannotta M; Misra R; Arebi N; Duricova D; Bortlik M; Gatt K; Ellul P; Pedersen N; Kjeldsen J; Andersen KW; Andersen V; Katsanos KH; Christodoulou DK; Sebastian S; Barros L; Magro F; Midjord JM; Nielsen KR; Salupere R; Kievit HA; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Kaimakliotis IP; Schwartz D; Odes S; Lakatos L; Lakatos PL; Langholz E; Munkholm P;
    United European Gastroenterol J; 2020 Oct; 8(8):949-960. PubMed ID: 32715989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-aminosalicylic acid dependency in Crohn's disease: a Danish Crohn Colitis Database study.
    Duricova D; Pedersen N; Elkjaer M; Jensen JK; Munkholm P
    J Crohns Colitis; 2010 Nov; 4(5):575-81. PubMed ID: 21122562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease.
    Thomson AB; Wright JP; Vatn M; Bailey RJ; Rachmilewitz D; Adler M; Wilson-Lynch KA
    Aliment Pharmacol Ther; 1995 Dec; 9(6):673-83. PubMed ID: 8824656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No Benefit of Continuing 5-Aminosalicylates in Patients with Crohn's Disease Treated with Anti-metabolite Therapy.
    Picetti D; Kim J; Zhu W; Sandborn WJ; Jairath V; Singh S
    Dig Dis Sci; 2022 Jul; 67(7):3115-3123. PubMed ID: 34797442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN.
    Atia O; Magen Rimon R; Ledderman N; Greenfeld S; Kariv R; Loewenberg Weisband Y; Shaoul R; Matz E; Odes S; Goren I; Yanai H; Dotan I; Turner D
    Inflamm Bowel Dis; 2024 Feb; 30(2):213-221. PubMed ID: 37084279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteral nutrition compared with corticosteroids in children with Crohn's disease: A long-term nationwide study from the epi-IIRN.
    Plotkin L; Buchuk R; Lujan R; Focht G; Greenfeld S; Kariv R; Weisband YL; Lederman N; Matz E; Dotan I; Reifen R; Turner D
    Aliment Pharmacol Ther; 2024 Jul; 60(2):224-232. PubMed ID: 38742605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic preferences and outcomes in newly diagnosed patients with Crohn's diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database.
    Kurti Z; Ilias A; Gonczi L; Vegh Z; Fadgyas-Freyler P; Korponay G; Golovics PA; Lovasz BD; Lakatos PL
    BMC Gastroenterol; 2018 Jan; 18(1):23. PubMed ID: 29378524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A watchful waiting approach for newly diagnosed Crohn's disease patients with an inflammatory phenotype.
    Yassin S; Isakov NF; Ron Y; Cohen NA; Hirsch A; Maharshak N
    Int J Colorectal Dis; 2021 Apr; 36(4):735-743. PubMed ID: 33404768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC; Hanauer S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteral nutrition for maintenance of remission in Crohn's disease.
    Akobeng AK; Zhang D; Gordon M; MacDonald JK
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD005984. PubMed ID: 30098021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adalimumab for maintenance of remission in Crohn's disease.
    Townsend CM; Nguyen TM; Cepek J; Abbass M; Parker CE; MacDonald JK; Khanna R; Jairath V; Feagan BG
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012877. PubMed ID: 32413933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.